The Valley Desk

ArticleCancer chemotherapy and pharmacologyPublished

Peptides derived from the POU domain of BRN2 show antitumor activity against murine melanoma model cells in vitro and in vivo

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Temple University. Affiliation source

Publication record

Type
Article
Venue
Cancer chemotherapy and pharmacology
Published
Subject terms
Cell Line, Tumor; Animals; Mice, Inbred C57BL; Humans; Mice; Melanoma; Melanoma, Experimental; Peptides; Homeodomain Proteins; Antineoplastic Agents; Cell Movement; POU Domain Factors
PubMed ID
40601014
Added to directory
Source checked

Report a correction or request removal